After a stem cell transplant, a cancer patient in the United States becomes the first woman to be HIV-free.
The example of a middle-aged mixed-race woman, presented in Denver at the Conference on Retroviruses and Opportunistic Infections, is also the first to use umbilical cord blood, a newer strategy that could make the treatment more accessible to more individuals.
The woman has remained in remission and clear of the virus for 14 months since getting cord blood to treat her acute myeloid leukaemia - a malignancy that develops in blood-forming cells in the bone marrow - without the need for powerful HIV medications known as antiretroviral therapy.
The two previous examples involved white and Latino men who had received adult stem cells, which are more commonly used in bone marrow transplants.
In a statement, Sharon Lewin, President-Elect of the International AIDS Society, said, "This is now the third report of a cure in this environment, and the first in a woman living with HIV."
Dr. Yvonne Bryson of the University of California, Los Angeles (UCLA) and Dr. Deborah Persaud of Johns Hopkins University in Baltimore are leading a larger US-funded investigation. Its goal is to monitor 25 HIV-positive persons who receive a stem cell transplant from umbilical cord blood for the treatment of cancer and other serious illnesses.
The malignant immune cells in the study participants are first treated with chemotherapy to kill them. Doctors then transplant stem cells from people who have an unique genetic mutation that prevents the virus from infecting cells.
These people, according to scientists, develop an immune system that is resistant to HIV.
Comments
Post a Comment